High Flow Through Nasal Cannula in Stable and Exacerbated Chronic Obstructive Pulmonary Disease Patients

Author(s): Andrea Bruni, Eugenio Garofalo, Gianmaria Cammarota, Paolo Murabito, Marinella Astuto, Paolo Navalesi, Francesco Luzza, Ludovico Abenavoli, Federico Longhini*.

Journal Name: Reviews on Recent Clinical Trials

Volume 14 , Issue 4 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: High-Flow through Nasal Cannula (HFNC) is a system delivering heated humidified air-oxygen mixture at a flow up to 60 L/min. Despite increasing evidence in hypoxemic acute respiratory failure, a few is currently known in chronic obstructive pulmonary disease (COPD) patients.

Objective: To describe the rationale and physiologic advantages of HFNC in COPD patients, and to systematically review the literature on the use of HFNC in stable and exacerbated COPD patients, separately.

Methods: A search strategy was launched on MEDLINE. Two authors separately screened all potential references. All (randomized, non-randomized and quasi-randomized) trials dealing with the use of HFNC in both stable and exacerbated COPD patients in MEDLINE have been included in the review.

Results: Twenty-six studies have been included. HFNC: 1) provides heated and humidified airoxygen admixture; 2) washes out the anatomical dead space of the upper airway; 3) generates a small positive end-expiratory pressure; 4) guarantees a more stable inspired oxygen fraction, as compared to conventional oxygen therapy (COT); and 5) is more comfortable as compared to both COT and non-invasive ventilation (NIV).

In stable COPD patients, HFNC improves gas exchange, the quality of life and dyspnea with a reduced cost of muscle energy expenditure, compared to COT. In exacerbated COPD patients, HFNC may be an alternative to NIV (in case of intolerance) and to COT at extubation or NIV withdrawal.

Conclusion: Though evidence of superiority still lacks and further studies are necessary, HFNC might play a role in the treatment of both stable and exacerbated COPD patients.

Keywords: Chronic obstructive pulmonary disease, high flow nasal cannula, hypercapnia, non-invasive ventilation, oxygen, positive-pressure respiration, respiratory insufficiency, respiratory therapy.

[1]
Renda T, Corrado A, Iskandar G, Pelaia G, Abdalla K, Navalesi P. High-flow nasal oxygen therapy in intensive care and anaesthesia. Br J Anaesth 2018; 120(1): 18-27.
[http://dx.doi.org/10.1016/j.bja.2017.11.010] [PMID: 29397127]
[2]
Pisani L, Vega ML. Use of nasal high flow in stable COPD: Rationale and physiology. COPD 2017; 14(3): 346-50.
[http://dx.doi.org/10.1080/15412555.2017.1315715] [PMID: 28459282]
[3]
Rochwerg B, Granton D, Wang DX, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med 2019; 45(5): 563-72.
[http://dx.doi.org/10.1007/s00134-019-05590-5] [PMID: 30888444]
[4]
Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J 2017; 49(3)1700214
[http://dx.doi.org/10.1183/13993003.00214-2017] [PMID: 28182564]
[5]
Ding H, Hu GL, Zheng XY, Chen Q, Threapleton DE, Zhou ZH. The method quality of cross-over studies involved in Cochrane Systematic Reviews. PLoS One 2015; 10(4)e0120519
[http://dx.doi.org/10.1371/journal.pone.0120519] [PMID: 25867772]
[6]
Plotnikow GA, Accoce M, Navarro E, Tiribelli N. Humidification and heating of inhaled gas in patients with artificial airway. A narrative review. Rev Bras Ter Intensiva 2018; 30(1): 86-97.
[PMID: 29742220]
[7]
Kilgour E, Rankin N, Ryan S, Pack R. Mucociliary function deteriorates in the clinical range of inspired air temperature and humidity. Intensive Care Med 2004; 30(7): 1491-4.
[http://dx.doi.org/10.1007/s00134-004-2235-3] [PMID: 15024566]
[8]
Konrad F, Schiener R, Marx T, Georgieff M. Ultrastructure and mucociliary transport of bronchial respiratory epithelium in intubated patients. Intensive Care Med 1995; 21(6): 482-9.
[http://dx.doi.org/10.1007/BF01706201] [PMID: 7560491]
[9]
Lacherade JC, Auburtin M, Cerf C, et al. Impact of humidification systems on ventilator-associated pneumonia: a randomized multicenter trial. Am J Respir Crit Care Med 2005; 172(10): 1276-82.
[http://dx.doi.org/10.1164/rccm.200408-1028OC] [PMID: 16126933]
[10]
De Pascale G, Ranzani OT, Nseir S, et al. Intensive care unit patients with lower respiratory tract nosocomial infections: The ENIRRIs project. ERJ Open Res 2017; 3(4): 00092-2017.
[http://dx.doi.org/10.1183/23120541.00092-2017] [PMID: 29164144]
[11]
Jiang M, Song JJ, Guo XL, Tang YL, Li HB. Airway humidification reduces the inflammatory response during mechanical ventilation. Respir Care 2015; 60(12): 1720-8.
[http://dx.doi.org/10.4187/respcare.03640] [PMID: 26329357]
[12]
Chidekel A, Zhu Y, Wang J, Mosko JJ, Rodriguez E, Shaffer TH. The effects of gas humidification with high-flow nasal cannula on cultured human airway epithelial cells. Pulm Med 2012.2012380686
[http://dx.doi.org/10.1155/2012/380686] [PMID: 22988501]
[13]
Hasani A, Chapman TH, McCool D, Smith RE, Dilworth JP, Agnew JE. Domiciliary humidification improves lung mucociliary clearance in patients with bronchiectasis. Chron Respir Dis 2008; 5(2): 81-6.
[http://dx.doi.org/10.1177/1479972307087190] [PMID: 18539721]
[14]
Rea H, McAuley S, Jayaram L, et al. The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med 2010; 104(4): 525-33.
[http://dx.doi.org/10.1016/j.rmed.2009.12.016] [PMID: 20144858]
[15]
Moller W, Celik G, Feng S, et al. Nasal high flow clears anatomical dead space in upper airway models. J Appl Physiol 1985; 105(3): 854-8.
[16]
Jiang Y, Liang Y, Kacmarek RM. The principle of upper airway unidirectional flow facilitates breathing in humans. J Appl Physiol 1985; 105(3): 854-8.
[17]
Elbehairy AF, Ciavaglia CE, Webb KA, et al. Pulmonary gas exchange abnormalities in mild chronic obstructive pulmonary disease. Implications for dyspnea and exercise intolerance. Am J Respir Crit Care Med 2015; 191(12): 1384-94.
[http://dx.doi.org/10.1164/rccm.201501-0157OC] [PMID: 25826478]
[18]
Bräunlich J, Seyfarth HJ, Wirtz H. Nasal high-flow versus non-invasive ventilation in stable hypercapnic COPD: A preliminary report. Multidiscip Respir Med 2015; 10(1): 27.
[http://dx.doi.org/10.1186/s40248-015-0019-y] [PMID: 26339486]
[19]
Di Mussi R, Spadaro S, Stripoli T, et al. High-flow nasal cannula oxygen therapy decreases postextubation neuroventilatory drive and work of breathing in patients with chronic obstructive pulmonary disease. Crit Care 2018; 22(1): 180.
[http://dx.doi.org/10.1186/s13054-018-2107-9] [PMID: 30071876]
[20]
Longhini F, Pisani L, Lungu R, et al. High-Flow oxygen therapy after noninvasive ventilation interruption in patients recovering from hypercapnic acute respiratory failure: A physiological crossover trial. Crit Care Med 2019; 47(6): e506-11.
[http://dx.doi.org/10.1097/CCM.0000000000003740] [PMID: 30882477]
[21]
Ritchie JE, Williams AB, Gerard C, Hockey H. Evaluation of a humidified nasal high-flow oxygen system, using oxygraphy, capnography and measurement of upper airway pressures. Anaesth Intensive Care 2011; 39(6): 1103-10.
[http://dx.doi.org/10.1177/0310057X1103900620] [PMID: 22165366]
[22]
Groves N, Tobin A. High flow nasal oxygen generates positive airway pressure in adult volunteers. Aust Crit Care 2007; 20(4): 126-31.
[http://dx.doi.org/10.1016/j.aucc.2007.08.001] [PMID: 17931878]
[23]
Garofalo E, Bruni A, Pelaia C, et al. Evaluation of a new interface combining high-flow nasal cannula and CPAP. Respir Care 2019; 64(10): 1231-9.
[http://dx.doi.org/10.4187/respcare.06871] [PMID: 31164484]
[24]
Parke RL, Eccleston ML, McGuinness SP. The effects of flow on airway pressure during nasal high-flow oxygen therapy. Respir Care 2011; 56(8): 1151-5.
[http://dx.doi.org/10.4187/respcare.01106] [PMID: 21496369]
[25]
Bräunlich J, Beyer D, Mai D, Hammerschmidt S, Seyfarth HJ, Wirtz H. Effects of nasal high flow on ventilation in volunteers, COPD and idiopathic pulmonary fibrosis patients. Respiration 2013; 85(4): 319-25.
[http://dx.doi.org/10.1159/000342027] [PMID: 23128844]
[26]
Dysart K, Miller TL, Wolfson MR, Shaffer TH. Research in high flow therapy: Mechanisms of action. Respir Med 2009; 103(10): 1400-5.
[http://dx.doi.org/10.1016/j.rmed.2009.04.007] [PMID: 19467849]
[27]
Mundel T, Feng S, Tatkov S, Schneider H. Mechanisms of nasal high flow on ventilation during wakefulness and sleep. J Appl Physiol 1985; 114(8): 1058-65.
[28]
Riera J, Pérez P, Cortés J, Roca O, Masclans JR, Rello J. Effect of high-flow nasal cannula and body position on end-expiratory lung volume: A cohort study using electrical impedance tomography. Respir Care 2013; 58(4): 589-96.
[http://dx.doi.org/10.4187/respcare.02086] [PMID: 23050520]
[29]
Corley A, Caruana LR, Barnett AG, Tronstad O, Fraser JF. Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. Br J Anaesth 2011; 107(6): 998-1004.
[http://dx.doi.org/10.1093/bja/aer265] [PMID: 21908497]
[30]
Lee CC, Mankodi D, Shaharyar S, et al. High flow nasal cannula versus conventional oxygen therapy and non-invasive ventilation in adults with acute hypoxemic respiratory failure: A systematic review. Respir Med 2016; 121: 100-8.
[http://dx.doi.org/10.1016/j.rmed.2016.11.004] [PMID: 27888983]
[31]
Maggiore SM, Idone FA, Vaschetto R, et al. Nasal high-flow versus Venturi mask oxygen therapy after extubation. Effects on oxygenation, comfort, and clinical outcome. Am J Respir Crit Care Med 2014; 190(3): 282-8.
[http://dx.doi.org/10.1164/rccm.201402-0364OC] [PMID: 25003980]
[32]
Appendini L, Patessio A, Zanaboni S, et al. Physiologic effects of positive end-expiratory pressure and mask pressure support during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 149(5): 1069-76.
[http://dx.doi.org/10.1164/ajrccm.149.5.8173743] [PMID: 8173743]
[33]
Pisani L, Fasano L, Corcione N, et al. Change in pulmonary mechanics and the effect on breathing pattern of high flow oxygen therapy in stable hypercapnic COPD. Thorax 2017; 72(4): 373-5.
[http://dx.doi.org/10.1136/thoraxjnl-2016-209673] [PMID: 28104830]
[34]
Sharma G, Mahler DA, Mayorga VM, Deering KL, Harshaw O, Ganapathy V. Prevalence of low peak inspiratory flow rate at discharge in patients hospitalized for COPD exacerbation. Chronic Obstr Pulm Dis (Miami) 2017; 4(3): 217-24.
[http://dx.doi.org/10.15326/jcopdf.4.3.2017.0183] [PMID: 28848933]
[35]
Elliott MW. The interface: Crucial for successful noninvasive ventilation. Eur Respir J 2004; 23(1): 7-8.
[http://dx.doi.org/10.1183/09031936.03.00115903] [PMID: 14738223]
[36]
Squadrone E, Frigerio P, Fogliati C, et al. Noninvasive vs invasive ventilation in COPD patients with severe acute respiratory failure deemed to require ventilatory assistance. Intensive Care Med 2004; 30(7): 1303-10.
[http://dx.doi.org/10.1007/s00134-004-2320-7] [PMID: 15197438]
[37]
Lellouche F, Maggiore SM, Lyazidi A, Deye N, Taillé S, Brochard L. Water content of delivered gases during non-invasive ventilation in healthy subjects. Intensive Care Med 2009; 35(6): 987-95.
[http://dx.doi.org/10.1007/s00134-009-1455-y] [PMID: 19294366]
[38]
Kallstrom TJ. AARC clinical practice guideline: oxygen therapy for adults in the acute care facility--2002 revision & update. Respir Care 2002; 47(6): 717-20.
[PMID: 12078655]
[39]
Jing G, Li J, Hao D, et al. Comparison of high flow nasal cannula with noninvasive ventilation in chronic obstructive pulmonary disease patients with hypercapnia in preventing postextubation respiratory failure: A pilot randomized controlled trial. Res Nurs Health 2019; 42(3): 217-25.
[http://dx.doi.org/10.1002/nur.21942] [PMID: 30887549]
[40]
Mauri T, Galazzi A, Binda F, et al. Impact of flow and temperature on patient comfort during respiratory support by high-flow nasal cannula. Crit Care 2018; 22(1): 120.
[http://dx.doi.org/10.1186/s13054-018-2039-4] [PMID: 29743098]
[41]
Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: A clinical trial. Ann Intern Med 1980; 93(3): 391-8.
[http://dx.doi.org/10.7326/0003-4819-93-3-391] [PMID: 6776858]
[42]
Katsenos S, Constantopoulos SH. Long-Term oxygen therapy in copd: Factors affecting and ways of improving patient compliance. Pulm Med 2011; 2011325362
[http://dx.doi.org/10.1155/2011/325362] [PMID: 21941649]
[43]
Bräunlich J, Köhler M, Wirtz H. Nasal highflow improves ventilation in patients with COPD. Int J Chron Obstruct Pulmon Dis 2016; 11: 1077-85.
[http://dx.doi.org/10.2147/COPD.S104616] [PMID: 27307723]
[44]
Fraser JF, Spooner AJ, Dunster KR, Anstey CM, Corley A. Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: A randomised crossover trial. Thorax 2016; 71(8): 759-61.
[http://dx.doi.org/10.1136/thoraxjnl-2015-207962] [PMID: 27015801]
[45]
Vogelsinger H, Halank M, Braun S, et al. Efficacy and safety of nasal high-flow oxygen in COPD patients. BMC Pulm Med 2017; 17(1): 143.
[http://dx.doi.org/10.1186/s12890-017-0486-3] [PMID: 29149867]
[46]
Atwood CW Jr, Camhi S, Little KC, et al. Impact of heated humidified high flow air via nasal cannula on respiratory effort in patients with chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis (Miami) 2017; 4(4): 279-86.
[http://dx.doi.org/10.15326/jcopdf.4.4.2016.0169] [PMID: 29354672]
[47]
Storgaard LH, Hockey HU, Laursen BS, Weinreich UM. Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure. Int J Chron Obstruct Pulmon Dis 2018; 13: 1195-205.
[http://dx.doi.org/10.2147/COPD.S159666] [PMID: 29713153]
[48]
Nagata K, Kikuchi T, Horie T, et al. Domiciliary high-flow nasal cannula oxygen therapy for patients with stable hypercapnic chronic obstructive pulmonary disease. A multicenter randomized crossover trial. Ann Am Thorac Soc 2018; 15(4): 432-9.
[http://dx.doi.org/10.1513/AnnalsATS.201706-425OC] [PMID: 29283682]
[49]
Biselli PJ, Kirkness JP, Grote L, et al. Nasal high-flow therapy reduces work of breathing compared with oxygen during sleep in COPD and smoking controls: A prospective observational study. J Appl Physiol 122(1): 82-8.
[50]
Cirio S, Piran M, Vitacca M, et al. Effects of heated and humidified high flow gases during high-intensity constant-load exercise on severe COPD patients with ventilatory limitation. Respir Med 2016; 118: 128-32.
[http://dx.doi.org/10.1016/j.rmed.2016.08.004] [PMID: 27578482]
[51]
Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017; 50(2)1602426
[http://dx.doi.org/10.1183/13993003.02426-2016] [PMID: 28860265]
[52]
Bruni A, Garofalo E, Pelaia C, et al. Patient-ventilator asynchrony in adult critically ill patients. Minerva Anestesiol 2019; 85(6): 676-88.
[http://dx.doi.org/10.23736/S0375-9393.19.13436-0] [PMID: 30762325]
[53]
Longhini F, Liu L, Pan C, et al. Neurally-adjusted ventilatory assist for noninvasive ventilation via a helmet in subjects with COPD exacerbation: A physiologic study. Respir Care 2019; 64(5): 582-9.
[http://dx.doi.org/10.4187/respcare.06502] [PMID: 30755472]
[54]
Cortegiani A, Garofalo E, Bruni A, Sanfilippo F, Longhini F. Predatory open-access publishing in palliative and supportive care. J Pain Symptom Manage 2019; 57(3): e1-3.
[http://dx.doi.org/10.1016/j.jpainsymman.2018.11.021] [PMID: 30595355]
[55]
Garofalo E, Bruni A, Pelaia C, et al. Recognizing, quantifying and managing patient-ventilator asynchrony in invasive and noninvasive ventilation. Expert Rev Respir Med 2018; 12(7): 557-67.
[http://dx.doi.org/10.1080/17476348.2018.1480941] [PMID: 29792537]
[56]
Vaschetto R, Longhini F, Persona P, et al. Early extubation followed by immediate noninvasive ventilation vs. standard extubation in hypoxemic patients: A randomized clinical trial. Intensive Care Med 2019; 45(1): 62-71.
[http://dx.doi.org/10.1007/s00134-018-5478-0] [PMID: 30535516]
[57]
Longhini F, Pan C, Xie J, et al. New setting of neurally adjusted ventilatory assist for noninvasive ventilation by facial mask: A physiologic study. Crit Care 2017; 21(1): 170.
[http://dx.doi.org/10.1186/s13054-017-1761-7] [PMID: 28683763]
[58]
Longhini F, Abdalla K, Navalesi P. Non-invasive ventilation in hypoxemic patients: Does the interface make a difference? Ann Transl Med 2016; 4(18): 359.
[http://dx.doi.org/10.21037/atm.2016.09.20] [PMID: 27761463]
[59]
Cammarota G, Longhini F, Perucca R, et al. New setting of neurally adjusted ventilatory assist during noninvasive ventilation through a helmet. Anesthesiology 2016; 125(6): 1181-9.
[http://dx.doi.org/10.1097/ALN.0000000000001354] [PMID: 27649505]
[60]
Costa R, Navalesi P, Cammarota G, et al. Remifentanil effects on respiratory drive and timing during pressure support ventilation and neurally adjusted ventilatory assist. Respir Physiol Neurobiol 2017; 244: 10-6.
[http://dx.doi.org/10.1016/j.resp.2017.06.007] [PMID: 28673877]
[61]
Liu L, Xia F, Yang Y, et al. Neural versus pneumatic control of pressure support in patients with chronic obstructive pulmonary diseases at different levels of positive end expiratory pressure: A physiological study. Crit Care 2015; 19: 244.
[http://dx.doi.org/10.1186/s13054-015-0971-0] [PMID: 26059238]
[62]
Longhini F, Scarlino S, Gallina MR, et al. Comparison of neurally-adjusted ventilator assist in infants before and after extubation. Minerva Pediatr 2018; 70(2): 133-40.
[PMID: 26583456]
[63]
Navalesi P, Longhini F. Neurally adjusted ventilatory assist. Curr Opin Crit Care 2015; 21(1): 58-64.
[http://dx.doi.org/10.1097/MCC.0000000000000167] [PMID: 25486574]
[64]
Vaschetto R, Cammarota G, Colombo D, et al. Effects of propofol on patient-ventilator synchrony and interaction during pressure support ventilation and neurally adjusted ventilatory assist. Crit Care Med 2014; 42(1): 74-82.
[http://dx.doi.org/10.1097/CCM.0b013e31829e53dc] [PMID: 23982026]
[65]
Cammarota G, Olivieri C, Costa R, et al. Noninvasive ventilation through a helmet in postextubation hypoxemic patients: Physiologic comparison between neurally adjusted ventilatory assist and pressure support ventilation. Intensive Care Med 2011; 37(12): 1943-50.
[http://dx.doi.org/10.1007/s00134-011-2382-2] [PMID: 22005826]
[66]
Longhini F, Colombo D, Pisani L, et al. Efficacy of ventilator waveform observation for detection of patient-ventilator asynchrony during NIV: A multicentre study. ERJ Open Res 2017; 3(4): 00075-2017.
[http://dx.doi.org/10.1183/23120541.00075-2017] [PMID: 29204431]
[67]
Okuda M, Kashio M, Tanaka N, et al. Nasal high-flow oxygen therapy system for improving sleep-related hypoventilation in chronic obstructive pulmonary disease: A case report. J Med Case Reports 2014; 8: 341.
[http://dx.doi.org/10.1186/1752-1947-8-341] [PMID: 25312578]
[68]
Lepere V, Messika J, La Combe B, Ricard JD. High-flow nasal cannula oxygen supply as treatment in hypercapnic respiratory failure. Am J Emerg Med 2016; 34(9): 1-2.
[http://dx.doi.org/10.1016/j.ajem.2016.02.020]
[69]
Plotnikow G, Thille AW, Vasquez D, Pratto R, Desmery P. High-flow nasal cannula oxygen for reverting severe acute exacerbation of chronic obstructive pulmonary disease: A case report. Med Intensiva 2017; 41(9): 571-2.
[http://dx.doi.org/10.1016/j.medin.2016.11.009] [PMID: 28089165]
[70]
Pavlov I, Plamondon P, Delisle S. Nasal high-flow therapy for type II respiratory failure in COPD: A report of four cases. Respir Med Case Rep 2017; 20: 87-8.
[http://dx.doi.org/10.1016/j.rmcr.2016.12.006] [PMID: 28123947]
[71]
Kim ES, Lee H, Kim SJ, et al. Effectiveness of high-flow nasal cannula oxygen therapy for acute respiratory failure with hypercapnia. J Thorac Dis 2018; 10(2): 882-8.
[http://dx.doi.org/10.21037/jtd.2018.01.125] [PMID: 29607161]
[72]
Pilcher J, Eastlake L, Richards M, et al. Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: A randomized controlled cross-over trial. Respirology 2017; 22(6): 1149-55.
[http://dx.doi.org/10.1111/resp.13050] [PMID: 28470831]
[73]
Zhang JC, Wu FX, Meng LL, Zeng CY, Lu YQ. A study on the effects and safety of sequential humidified high flow nasal cannula oxygenation therapy on the COPD patients after extubation. Zhonghua Yi Xue Za Zhi 2018; 98(2): 109-12.
[PMID: 29343034]
[74]
Crimi C, Noto A, Princi P, Esquinas A, Nava S. A European survey of noninvasive ventilation practices. Eur Respir J 2010; 36(2): 362-9.
[http://dx.doi.org/10.1183/09031936.00123509] [PMID: 20075052]
[75]
Antonelli M, Conti G, Pelosi P, et al. New treatment of acute hypoxemic respiratory failure: noninvasive pressure support ventilation delivered by helmet--a pilot controlled trial. Crit Care Med 2002; 30(3): 602-8.
[http://dx.doi.org/10.1097/00003246-200203000-00019] [PMID: 11990923]
[76]
Patel BK, Wolfe KS, Pohlman AS, Hall JB, Kress JP. Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: A randomized clinical trial. JAMA 2016; 315(22): 2435-41.
[http://dx.doi.org/10.1001/jama.2016.6338] [PMID: 27179847]
[77]
Navalesi P, Costa R, Ceriana P, et al. Non-invasive ventilation in chronic obstructive pulmonary disease patients: Helmet versus facial mask. Intensive Care Med 2007; 33(1): 74-81.
[http://dx.doi.org/10.1007/s00134-006-0391-3] [PMID: 17039354]
[78]
Olivieri C, Costa R, Spinazzola G, et al. Bench comparative evaluation of a new generation and standard helmet for delivering non-invasive ventilation. Intensive Care Med 2013; 39(4): 734-8.
[http://dx.doi.org/10.1007/s00134-012-2765-z] [PMID: 23223773]
[79]
Olivieri C, Longhini F, Cena T, et al. New versus conventional helmet for delivering noninvasive ventilation: A physiologic, crossover randomized study in critically Ill patients. Anesthesiology 2016; 124(1): 101-8.
[http://dx.doi.org/10.1097/ALN.0000000000000910] [PMID: 26528774]
[80]
Vaschetto R, De Jong A, Conseil M, et al. Comparative evaluation of three interfaces for non-invasive ventilation: a randomized cross-over design physiologic study on healthy volunteers. Crit Care 2014; 18(1): R2.
[http://dx.doi.org/10.1186/cc13175] [PMID: 24387642]
[81]
Pisani L, Mega C, Vaschetto R, et al. Oronasal mask versus helmet in acute hypercapnic respiratory failure. Eur Respir J 2015; 45(3): 691-9.
[http://dx.doi.org/10.1183/09031936.00053814] [PMID: 25504992]
[82]
Ricard JD, Dib F, Esposito-Farese M, Messika J, Girault C. Comparison of high flow nasal cannula oxygen and conventional oxygen therapy on ventilatory support duration during acute-on-chronic respiratory failure: study protocol of a multicentre, randomised, controlled trial. The ‘HIGH-FLOW ACRF’ study. BMJ Open 2018; 8(9)e022983
[http://dx.doi.org/10.1136/bmjopen-2018-022983] [PMID: 30232113]
[83]
Nishimura M. High-flow nasal cannula oxygen therapy in adults. J Intensive Care 2015; 3(1): 15.
[http://dx.doi.org/10.1186/s40560-015-0084-5] [PMID: 25866645]
[84]
Zhang Z, Xu X, Ni H. Small studies may overestimate the effect sizes in critical care meta-analyses: A meta-epidemiological study. Crit Care 2013; 17(1): R2.
[http://dx.doi.org/10.1186/cc11919] [PMID: 23302257]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 14
ISSUE: 4
Year: 2019
Page: [247 - 260]
Pages: 14
DOI: 10.2174/1574887114666190710180540
Price: $65

Article Metrics

PDF: 37
HTML: 3
PRC: 1